We are live on ! Find out more
TGI

TRV GP IV Portfolio holdings

AUM $267M
1-Year Est. Return 965.83%
This Fund
S&P 500
This Quarter Est. Return
-32.77%
1 Year Est. Return
+965.83%
3 Year Est. Return
+686.22%
5 Year Est. Return
+581.56%
10 Year Est. Return
AUM
$80.2M
AUM Growth
-$81.9M
Cap. Flow
-$8.37M
Cap. Flow %
-10.43%
Top 10 Hldgs %
100%
Holding
3
New
Increased
Reduced
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
FULC icon
Fulcrum Therapeutics
FULC
+$8.37M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TNGX icon
1
Tango Therapeutics
TNGX
$4.43B
$52.1M 64.97%
16,859,075
PLRX icon
2
Pliant Therapeutics
PLRX
$64.4M
$28.1M 35.03%
2,132,867
FULC icon
3
Fulcrum Therapeutics
FULC
$273M
-2,343,154
Closed -$8.37M

Similar funds

TRV GP IV's Q4 2024 Portfolio in Review

As of Q4 2024, TRV GP IV held 3 positions worth $80.2M, down 51% from $162M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

TRV GP IV withdrew a net $8.37M in Q4 2024, closing 1 position. Its most notable exit was Fulcrum Therapeutics, an estimated $8.37M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • TRV GP IV fully exited Fulcrum Therapeutics in Q4 2024, selling an estimated $8.37M.
  • TRV GP IV's ten largest holdings make up 100% of its $80.2M portfolio in Q4 2024.
  • TRV GP IV opened 0 new positions and closed 1 in Q4 2024.
  • TRV GP IV's portfolio value fell 51% quarter-over-quarter to $80.2M.

Based on TRV GP IV's 13F filing for Q4 2024, filed 13 Feb 2025.